TRCT
LVGO

Tower Research Capital (TRC)’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Tower Research Capital (TRC)’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-138
Closed -$19K – 5622
2020
Q3 		$19K Sell
138
-7,073
-98% -$862K ﹤0.01% 3890
2020
Q2 		$542K Buy
+7,211
New +$377K 0.02% 955

Tower Research Capital (TRC)'s LVGO Position: Q4 2020 in Review

Tower Research Capital (TRC) sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 138 shares — an estimated $19K sold.

Tower Research Capital (TRC) first reported a position in LVGO in Q2 2020 and held it in 2 quarters. The position peaked at $542K in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Tower Research Capital (TRC) reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 138 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19K.
  • Tower Research Capital (TRC) first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Livongo Health, Inc. Common Stock position peaked at $542K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.